SREBF1 and metabolic dysfunction-associated steatotic liver disease: Research has demonstrated that fatty acid synthesis in the liver is regulated by both insulin and glucose, with membrane-bound transcription factors such as SREBP-1c and ChREBP, along with PPARγ and AMPK, playing crucial roles in NAFLD pathogenesis through their involvement in the independent regulation of adipogenesis-related enzyme transcription and activity [74].